期刊文献+

228株铜绿假单胞菌临床分布及耐药性分析 被引量:6

Clinical distribution and drug resistance of 228 strains of Pseudomonas aeruginosa
下载PDF
导出
摘要 目的分析铜绿假单胞菌(PAE)临床分布特点及耐药性,为临床合理用药提供依据。方法回顾性分析本院2010年5月至2011年12月分离的228株PAE临床分布特点及耐药性。结果 228株PAE主要来源于呼吸内科、重症监护病房和脑外科,分别占36.9%、27.2%和23.2%;阳性标本主要为痰液,占72.4%;对头孢哌酮/舒巴坦、亚胺培南、美罗培南和阿卡米星耐药率较低,分别为0.0%、8.9%、9.6%和8.3%;对氨苄西林、头孢唑啉和头孢噻肟耐药率大于67.0%;对头孢他啶、头孢吡肟和哌拉西林/他唑巴坦耐药率小于30.0%。结论 PEA耐药性较强,应加强耐药性监测,规范抗菌药物的应用。 Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(PAE) to provide references for rational usage of antibiotics in clinic.Methods The characteristics of clinical distribution and drug resistance of 228 strains of PAE,isolated from May.2010 to Dec.2011 in this hospital,were retrospectively analyzed.Results Among 228 PAE isolates,most were collected from Respiratory Department,ICU and Department of Cerebral Surgery,accounting for 36.9%,27.2% and 23.2%.165 strains were isolated from sputum,accounting for 72.4%.The drug resistance rates of PAE to cefoperazone/sulbactam,imipenem,meropenem and amikacin were 0.0%,8.9%,9.6% and 8.3% respectively,to ampicillin,cefazolin and cefotaxime were higher than 67.0% and to ceftazidime,cefepime and piperacillin/tazobactam were lower than 30.0%.Conclusion The drug resistance of PAE might be serious.It should be strengthened to reinforce the monitoring on drug resistance and to standardize the application of antibacterials.
出处 《检验医学与临床》 CAS 2013年第11期1417-1418,共2页 Laboratory Medicine and Clinic
关键词 铜绿假单胞菌 药敏试验 耐药率 Pseudomonas aeruginosa drug sensitivity test drug resistance rate
  • 相关文献

参考文献10

二级参考文献59

共引文献313

同被引文献61

  • 1张祎博,倪语星,孙景勇,朱德妹,胡付品,汪复,蒋晓飞,俞云松,杨青,孙自镛,简翠,徐英春,孙宏莉,胡云建,艾效曼,单斌,杜艳,苏丹虹,卓超,徐元宏,沈继录,王传清,王爱敏,贾蓓,黄文祥,魏莲花,吴玲,张朝霞,季萍,张泓,李万华.2009年中国CHINET铜绿假单胞菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):436-440. 被引量:74
  • 2崔进,冯旰珠,赵水娣,秦湧,杜强,王新云.多重耐药铜绿假单胞菌β内酰胺类抗生素耐药基因和膜孔蛋白基因研究[J].中国感染与化疗杂志,2010,10(6):472-476. 被引量:8
  • 3倪语星.2005年中国CHINET铜绿假单胞菌耐药性分析[J].中国感染与化疗杂志,2007,7(4):274-278. 被引量:49
  • 4Yamagishi Y, Terada M, Ohki E, et al. Investigation of the clini- cal breakpoints of piperacillin - tazobactam against infections caused by Pseudomonas aeruginosa[J]. Infect Chemother, 2012, 18( 1 ) : 127 - 136.
  • 5Zhao WH, Hu Z, Chen G, et al. Contributions of IMP - 10 metallo - 13 -lactamase, the outer membrane barrier and the MexAB - OprM efflux system to high - level carbapenem resistance inPseudomonas aeruginosa [ J 1. Chemotherapy, 2009, 55 (3) : 168 - 174.
  • 6Jeannot K, Elsen S, Kohler T, eta/. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD - OprJ efflux pump [ J ]. Antimierob Agents Chemother, 2008, 52 (7) : 2455 -2462.
  • 7Olivares J, Alvarez - Ortega C, Linares JF, et al. Overproduction of the multidrug efflux pump MexEF - OprN does not impair Pseud- omonas aeruginosa fitness in competition tests, but produces specif- ic changes in bacterial regulatory networks [ J ]. Environ Microbiol, 2012, 14(8) : 1968 -1981.
  • 8Pechere JC, Kohler T. Patterns and modes of 13 - laetam resistance in Pseudomonas aeruginosa[ J]. Clin Mircobiol Infect, 1999, 5 (1) : S15 -S18.
  • 9Krause A, Whu WZ, Qiu J, et al. RGD capsid modification en- hances mucosal protective immunity of a non - human primate ade- novirus vector expressing Pseudomonas aeruginosa OprF [ J ]. Clin Exp Immunol, 2013, 173(2) : 230 -241.
  • 10Edrington TC, Kintz E, Goldberg JB, et al. Structural basis for the interaction of lipopolysaceharide with outer membrane protein H (OprH) from Pseudomonas aerunosa[J]. J Biol Chem, 2011, 286 (45) : 39211 - 39223.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部